Intrinsic Value of S&P & Nasdaq Contact Us

Sight Sciences, Inc. SGHT NASDAQ

NASDAQ Global Select • Healthcare • Medical - Devices • US • USD

SharesGrow Score
48/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$9.67
+153.1%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Sight Sciences, Inc. (SGHT) has a negative trailing P/E of -4.7, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -21.10%.

Criteria proven by this page:

  • VALUE (100/100, Pass) — analyst target implies upside (+153.1%).
  • Trailing Earnings Yield -21.10% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings.
  • Analyst consensus target $9.67 (+153.1% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 48/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
48/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
~
FUTURE
52/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
50/100
→ Income
GROWTH
73/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — SGHT

Valuation Multiples
P/E (TTM)-4.7
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio2.85
P/S Ratio2.39
EV/EBITDA-3.7
Per Share Data
EPS (TTM)$-0.72
Book Value / Share$1.20
Revenue / Share$1.46
FCF / Share$-0.56
Yields & Fair Value
Earnings Yield-21.10%
Dividend Yield0.00%
Analyst Target$9.67 (+153.1%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2018 -75.5 0.00 -37.25 143.27 -
2019 -43.5 -1.74 -20.60 48.25 -
2020 -45.2 -1.31 -17.63 56.68 -
2021 -13.3 -0.17 3.60 17.05 -
2022 -6.8 -0.19 3.65 8.19 -
2023 -4.5 0.12 2.09 3.10 -
2024 -3.5 0.37 2.09 2.28 -
2025 -10.8 0.38 6.47 5.35 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2018 $-0.44 $7.53M $-14.29M -189.8%
2019 $-0.55 $23.35M $-25.87M -110.8%
2020 $-0.74 $27.64M $-34.69M -125.5%
2021 $-1.33 $48.96M $-62.96M -128.6%
2022 $-1.80 $71.33M $-86.24M -120.9%
2023 $-1.14 $81.06M $-55.55M -68.5%
2024 $-1.03 $79.87M $-51.51M -64.5%
2025 $-0.74 $77.36M $-38.43M -49.7%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-0.61 $-0.79 – $-0.47 $84.56M $84.31M – $84.89M 4
2027 $-0.50 $-0.78 – $-0.33 $94.46M $91.68M – $97.61M 4
2028 $-0.44 $-0.56 – $-0.32 $105.02M $105.02M – $105.02M 2
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message